NICE Reform Plans Aim To Help Make Post-Brexit UK A ‘First-Launch’ Country
HTA Body's Methodology Review Includes Accepting More Uncertainty
Following a Brexit-induced delay over the summer, England's HTA body NICE has come up with a concrete set of proposals that it says will help it “robustly and efficiently” evaluate innovative technologies such as advanced therapies, histology-independent cancer treatments, and technologies for rare diseases. Industry bodies have welcomed the plans, which have just been put out for consultation.
